Cargando...
NYSE: JNJ
Operaciones reportadas en formularios SEC Form 4. Las compras se muestran en verde y las ventas en rojo.
| Fecha | Insider | Cargo | Operación | Acciones | Precio | Valor total |
|---|---|---|---|---|---|---|
| 01/05/2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Exercise | 25.255 | $0,00 | $0 |
| 01/05/2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Tax Withholding | 11.002 | $229,85 | $2,5M |
| 01/05/2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Unknown | 25.255 | $0,00 | $0 |
| 23/04/2026 | Eugene A. Woods | Director | Unknown | 975 | $0,00 | $0 |
| 23/04/2026 | Nadja West | Director | Unknown | 975 | $0,00 | $0 |
| 23/04/2026 | Mark A Weinberger | Director | Unknown | 975 | $0,00 | $0 |
| 23/04/2026 | Daniel E Pinto | Director | Unknown | 1.712 | $0,00 | $0 |
| 23/04/2026 | John G Morikis | Director | Unknown | 1.540 | $0,00 | $0 |
| 23/04/2026 | Mark B. Mcclellan | Director | Unknown | 975 | $0,00 | $0 |
| 23/04/2026 | Hubert Joly | Director | Unknown | 975 | $0,00 | $0 |
| 23/04/2026 | Paula A Johnson | Director | Unknown | 975 | $0,00 | $0 |
| 23/04/2026 | Marillyn A Hewson | Director | Unknown | 975 | $0,00 | $0 |
| 23/04/2026 | Jennifer A Doudna | Director | Unknown | 975 | $0,00 | $0 |
| 23/04/2026 | Mary C Beckerle | Director | Unknown | 975 | $0,00 | $0 |
| 10/03/2026 | Marillyn A Hewson | Director | Unknown | 206 | $242,14 | $50,0K |
| 10/03/2026 | Daniel E Pinto | Director | Unknown | 129 | $242,14 | $31,3K |
| 10/03/2026 | Eugene A. Woods | Director | Unknown | 155 | $242,14 | $37,5K |
| 27/02/2026 | Robert J Decker | VP Corporate Controller | Exercise | 4.075 | $115,67 | $471,4K |
| 27/02/2026 | Robert J Decker | VP Corporate Controller | Sale | 4.075 | $247,87 | $1,0M |
| 27/02/2026 | Robert J Decker | VP Corporate Controller | Unknown | 4.075 | $0,00 | $0 |
| 20/02/2026 | Timothy Schmid | EVP, WW Chair, MedTech | Sale | 1.322 | $245,66 | $324,8K |
| 18/02/2026 | Timothy Schmid | EVP, WW Chair, MedTech | Exercise | 13.625 | $115,67 | $1,6M |
| 18/02/2026 | Timothy Schmid | EVP, WW Chair, MedTech | Sale | 13.625 | $244,20 | $3,3M |
| 18/02/2026 | Timothy Schmid | EVP, WW Chair, MedTech | Exercise | 8.998 | $129,51 | $1,2M |
| 18/02/2026 | Timothy Schmid | EVP, WW Chair, MedTech | Sale | 8.998 | $244,53 | $2,2M |
| 18/02/2026 | Timothy Schmid | EVP, WW Chair, MedTech | Unknown | 13.625 | $0,00 | $0 |
| 18/02/2026 | Timothy Schmid | EVP, WW Chair, MedTech | Unknown | 8.998 | $0,00 | $0 |
| 17/02/2026 | James D. Swanson | EVP, CIO | Exercise | 20.521 | $164,62 | $3,4M |
| 17/02/2026 | James D. Swanson | EVP, CIO | Sale | 20.521 | $242,70 | $5,0M |
| 17/02/2026 | James D. Swanson | EVP, CIO | Unknown | 20.521 | $0,00 | $0 |
| 17/02/2026 | Joseph J Wolk | Exec VP, CFO | Exercise | 19.241 | $115,67 | $2,2M |
| 17/02/2026 | Joseph J Wolk | Exec VP, CFO | Sale | 19.241 | $242,99 | $4,7M |
| 17/02/2026 | Joseph J Wolk | Exec VP, CFO | Exercise | 12.066 | $129,51 | $1,6M |
| 17/02/2026 | Joseph J Wolk | Exec VP, CFO | Sale | 12.066 | $242,87 | $2,9M |
| 17/02/2026 | Joseph J Wolk | Exec VP, CFO | Exercise | 33.386 | $131,94 | $4,4M |
| 17/02/2026 | Joseph J Wolk | Exec VP, CFO | Sale | 33.386 | $242,75 | $8,1M |
| 17/02/2026 | Joseph J Wolk | Exec VP, CFO | Sale | 24.961 | $242,68 | $6,1M |
| 17/02/2026 | Joseph J Wolk | Exec VP, CFO | Unknown | 19.241 | $0,00 | $0 |
| 17/02/2026 | Joseph J Wolk | Exec VP, CFO | Unknown | 12.066 | $0,00 | $0 |
| 17/02/2026 | Joseph J Wolk | Exec VP, CFO | Unknown | 33.386 | $0,00 | $0 |
| 17/02/2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Exercise | 21.721 | $157,92 | $3,4M |
| 17/02/2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Sale | 21.721 | $243,00 | $5,3M |
| 17/02/2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Exercise | 29.927 | $156,15 | $4,7M |
| 17/02/2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Sale | 29.927 | $243,00 | $7,3M |
| 17/02/2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Sale | 2.283 | $243,00 | $554,8K |
| 17/02/2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Unknown | 21.721 | $0,00 | $0 |
| 17/02/2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Unknown | 29.927 | $0,00 | $0 |
| 17/02/2026 | Vanessa Broadhurst | EVP, Global Corp Affairs | Sale | 6.197 | $243,39 | $1,5M |
| 15/02/2026 | James D. Swanson | EVP, CIO | Exercise | 492 | $0,00 | $0 |
| 15/02/2026 | James D. Swanson | EVP, CIO | Tax Withholding | 214 | $243,45 | $52,1K |
Principales tenedores institucionales por valor de la posición.
| Holder | Tipo | % del flotante | Acciones | Valor | Reportado |
|---|---|---|---|---|---|
| Vanguard Group Inc | Institución | 0,10% | 240.349.660 | $53,2B | 31/12/2025 |
| Blackrock Inc. | Institución | 0,09% | 208.781.159 | $46,2B | 31/12/2025 |
| State Street Corporation | Institución | 0,06% | 133.869.843 | $29,6B | 31/12/2025 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | Fondo | 0,03% | 75.728.761 | $16,8B | 31/12/2025 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | Fondo | 0,03% | 60.753.681 | $13,4B | 31/12/2025 |
| JPMORGAN CHASE & CO | Institución | 0,02% | 58.558.238 | $13,0B | 31/12/2025 |
| Geode Capital Management, LLC | Institución | 0,02% | 57.953.747 | $12,8B | 31/12/2025 |
| Morgan Stanley | Institución | 0,02% | 46.325.589 | $10,3B | 31/12/2025 |
| NORGES BANK | Institución | 0,01% | 33.459.884 | $7,4B | 31/12/2025 |
| State Farm Mutual Automobile Insurance Co | Institución | 0,01% | 31.590.952 | $7,0B | 31/12/2025 |